Hans-Peter Schupp
Investor
Hans-Peter Schupp is an investor at the Fidecum fund management company, noted for his analysis of BASF's potential acquisition of Evonik amid a challenging chemical market, highlighting the anticyclical nature of the move.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Hans-Peter Schupp from the Fidecum investment company has invested about 4% of the capital in BASF.
7
Markus Kamieth
Kurt Bock
Sebastian Satz
Matt White
Joe Kaeser
Georg Wallwitz
Sanjiv Lamba
Victoria Ossadnik
Ann Kristin Achleitner
Thomas Enders
Donald Trump
Tom Gayner
Neue Zürcher Zeitung: BASF greift nach Evonik und trotzt damit der schlechten Chemiekonjunktur